RevIT™ AAV Enhancer | White Paper

Rev up your AAV genome production in upstream process development and manufacturing

Designed to deliver a higher AAV titer for:

• Any serotype
• Any transfection reagent
• Any HEK 293 cell line
• Any media

Mirus Bio has developed the RevIT AAV Enhancer to further increase AAV genome titers in suspension 293-derived cells.

This novel enhancer is easily integrated into existing workflows and produces 2-4X* higher titers across a range of serotypes, cellular growth media formulations, and transfection platforms.

The RevIT AAV Enhancer can further drive down upstream manufacturing costs by lowering levels of plasmid DNA while maintaining high-quality titers.